US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 88.860
  • -1.210-1.34%
Trading Apr 19 14:18 ET
16.86BMarket Cap102.14P/E (TTM)

About Biomarin Pharmaceutical Company

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Company Profile

SymbolBMRN
Company NameBiomarin Pharmaceutical
Listing DateJul 23, 1999
Issue Price13.00
Founded1997
CEOMr. Alexander Hardy
MarketNASDAQ
Employees3401
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address770 Lindaro Street
CitySan Rafael
ProvinceCalifornia
CountryUnited States of America
Zip Code94901
Phone1-415-506-6700
Websitehttp://www.biomarin.com

Company Executives

  • Name
  • Position
  • Salary
  • Alexander Hardy
  • Director, President and Chief Executive Officer
  • 17.88M
  • Erin Burkhart
  • Group Vice President and Chief Accounting Officer
  • --
  • Brian R. Mueller
  • Executive Vice President and Chief Financial Officer
  • 4.85M
  • Charles Greg Guyer
  • Chief Technical Officer and Executive Vice President
  • 5.70M
  • G. Eric Davis
  • Executive Vice President, Chief Legal Officer and Secretary
  • --
  • Jeffrey R. Ajer
  • Executive Vice President and Chief Commercial Officer
  • 5.07M
  • Richard A. Meier
  • Chairman of the Board
  • 515.44K
  • Dr. Henry J. Fuchs,M.D.
  • President, Worldwide Research and Development
  • 9.66M
  • Jean-Jacques Bienaime
  • Director
  • 21.98M
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 470.44K
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 480.44K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 473.94K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 480.44K
  • Barbara W. Bodem
  • Independent Director
  • 213.38K
  • Mark J. Alles
  • Independent Director
  • 483.94K
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 470.44K
  • Dr. Athena Countouriotis, M.D.
  • Independent Director
  • 213.38K
  • Mark Joseph Enyedy
  • Independent Director
  • 213.38K
  • Dr. Elaine J. Heron,PhD
  • Independent Director
  • 486.44K
  • Robert J. Hombach
  • Independent Director
  • 486.94K
  • Dr. Dennis J. Slamon, M.D.,PhD
  • Independent Director
  • 460.44K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg